|
|
|
Visit Mirati at ASCO Booth #2097
|
|
|
|
Mirati is relentlessly focused on targeting the genetic and immunological drivers of cancer to ultimately help improve the lives of patients with cancer.
|
|
|
|
We are excited to exhibit at our first ASCO and hope you will visit our booth to learn more about our pipeline of novel therapeutics.
|
|
|
|
|
|
|
|
|
|
|
|
You can find us here:
|
|
|
|
|
|
|
|
|
|
TERMS OF USE
| PRIVACY POLICY | CONTACT | UNSUBSCRIBE
|
|
This e-mail is intended for U.S. healthcare professionals only. This e-mail is brought to you by Mirati Therapeutics. This e-mail is intended for the recipient identified above. If you have received this e-mail in error, please notify the sender immediately and delete the e-mail from your system.
|
|
Mirati Therapeutics and associated logos are trademarks of Mirati Therapeutics, Inc.
|
|
Mirati Therapeutics, Inc.
3545 Cray Court, San Diego, CA 92121
|
|
© 2022 Mirati Therapeutics, Inc.
US-NP-22-00116
|
|
|
|
|
|
|
|
|
|
|
TERMS OF USE | PRIVACY POLICY | CONTACT | UNSUBSCRIBE |
|
This e-mail is intended for U.S. healthcare professionals only. This e-mail is brought to you by Mirati Therapeutics. This e-mail is intended for the recipient identified above. If you have received this e-mail in error, please notify the sender immediately and delete the e-mail from your system.
|
|
Mirati Therapeutics and associated logos are trademarks of Mirati Therapeutics, Inc.
|
|
Mirati Therapeutics, Inc.
3545 Cray Court, San Diego, CA 92121
|
|
© 2022 Mirati Therapeutics, Inc.
US-NP-22-00116
|
|
|
|
|
|
|
|
|
|
|